onabotulinumtoxinA

Revance injectable outperforms BotoxAccording to early research, not-yet-approved RT002 (DaxibotulinumtoxinA for Injection, Revance Therapeutics) lasts longer, might be safer and offers more dramatic wrinkle reduction than today’s most popular neurotoxin Botox (Allergan).
Neurotoxin pipeline advances, stay wary of counterfeitsAs the neurotoxin market is set for expansion, so expands the market of counterfeit products. One expert reviews the innovative options coming up through the pipeline and cautions colleagues about the risks associated with counterfeits.
Botulinum reduces pain in interstitial cystitis, BPSIntravesical onabotulinumtoxinA (Botox) reduces bladder pain in patients with interstitial cystitis/bladder pain syndrome (IC/BPS), two separate studies show.
Be vigilant of counterfeit version of Botox found in United StatesA counterfeit version of onabotulinumtoxinA (Botox) was found in the United States and may have been sold to doctors’ offices and medical clinics nationwide. The version is considered unsafe and should not be used.
‘Continued success’ seen with botulinum injections
‘Continued success’ seen with botulinum injectionsRepeated onabotulinumtoxinA 100 U (onabotA [Botox]) injections continue to provide benefit for patients with overactive bladder syndrome and urinary incontinence and without evidence of any new safety concerns, according to results of a pre-specified interim analysis in an open-label, 3-year extension study.
Risk of nodules associated with fillers, dental work (VIDEO)Listen to the expert panel discuss this issue in our exclusive roundtable video from the Vegas Cosmetic Surgery and Aesthetic Dermatology meeting.
Best of AUA 2014: Female Urology/Incontinence/UrodynamicsAdonis K. Hijaz, MD, presents the take home messages on female urology/incontinence/urodynamics from the AUA annual meeting in Orlando, FL, including studies on mesh outcomes and the overactive bladder treatment mirabegron (Myrbetriq).
Neuromodulator, cosmeceutical product options expandingNoteworthy products under development include modified neuromodulators that can function as carrier molecules, as well as a promising wrinkle- and redness-reducing cosmeceutical, experts say.
OAB patients benefit consistently from repeat onabotARepeated injections of onabotulinumtoxinA (onabotA [Botox]), 100 U, continue to provide benefit in patients with overactive bladder syndrome and urinary incontinence and without any new safety concerns, according to results of a pre-specified interim analysis in an open-label, 3-year extension study.
Female urology research examines sling surgery, robotic approaches, meshSling surgery, robotic approaches to sacrocolpopexy and pelvic organ prolapse, and mesh are among the key studies in the area of female urology to watch for at the 2014 AUA annual meeting.